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Objective: In order to compare their validity, this review applies scientiﬁ  c standards for sustain-
ing the neuroses, the schizophrenias and bipolar disorders as separate “bona-ﬁ  de” psychiatric 
diseases. The standards for disease validation demand speciﬁ  c and unique symptoms.
Method: We review a wide variety of clinical and basic science comparisons between schizo-
phrenia and psychotic bipolar in a select English-language literature.
Results: Like covered wagons, the neuroses once served us well but became obsolete and were 
discarded or reorganized based on what was known about commonalities of symptoms, causation 
and pharmacological responsivity. Bipolar patients meet unique and speciﬁ  c diagnostic criteria 
and demonstrate consistent results across a variety of scientiﬁ  c disciplines. Neither the neuroses 
nor the schizophrenias have such unique or disease speciﬁ  c diagnostic criteria. Psychotic mood 
disorders account for the DSM diagnostic criteria for schizophrenia. A recent, selected but 
diverse basic science literature demonstrates surprising similarities between schizophrenia and 
psychotic bipolar which should not exist if these disorders are distinct.
Conclusions: Like the neuroses, there is stigma, confusion and misunderstanding about the 
condition called schizophrenia, resulting in substantial negative impact on bipolar patients 
misdiagnosed as having schizophrenia. The psychoses, including the schizophrenias, likely are 
explained by a single disease, psychotic bipolar disorder, that has demonstrated a wide spectrum 
of severity of symptoms and chronicity of course, not traditionally recognized. 
Keywords: schizophrenia, mania, depression, bipolar mood disorder, neurosis, psychosis, 
Kraepelinian dichotomy
A history of the neuroses and the schizophrenias
In contrast to some medical specialties where diagnostic criteria are based on objective 
and often quantiﬁ  able pathophysiology, the diagnostic criteria of psychiatric disorders 
depend largely on subjective interviews, observations and opinions. Between the 
mid 19th and mid 20th centuries, the absence of objective ﬁ  ndings stimulated indi-
vidual mental health professionals to create their own idiosyncratic, redundant and 
often confusing names and diagnostic criteria for various psychiatric syndromes and 
subtypes. During this time mental illness was divided into two groups, the neuroses 
and the psychoses, the latter being further subdivided into the schizophrenias and 
manic-depressive insanity with schizophrenia the dominant disease of the two. The 
neuroses, with few exceptions, were less disabling than the schizophrenias. Patients 
called neurotic were likely to function adequately in most aspects of job, family life, 
and society with only a circumscribed area of dysfunction that could lead to temporary 
incapacitation. In contrast, patients diagnosed with schizophrenia were more glob-
ally dysfunctional and for longer periods of time, often spending months to years in 
psychiatric hospitals. While the neuroses were treated with psychoanalysis or other 
“talk therapies,” the schizophrenias received more invasive physical treatments or Neuropsychiatric Disease and Treatment 2007:3(1) 134
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management including cold showers, various wraps and 
straight jackets, insulin and electro-shock therapies, and 
neurotoxic, antipsychotic drugs. Some of these may have 
constituted punishments. According to Freud, the neuroses 
were caused by ﬁ  xations in personality development in child-
hood that led to personality and behavioral dysfunctions in 
adulthood. Early descriptions of the schizophrenias blamed 
organic brain defects. Freud’s groupings of adult symptoms 
formed the foundations for the classiﬁ  cation of the neuroses, 
(Table 2b) while the opinions of Kraepelin, Bleuler, Schneider, 
and others, discussed below, established the current diag-
nostic criteria and subtypes of the schizophrenias and the 
concept that manic-depressive insanity (bipolar disorder) 
was a separate, minor disorder (Tables 1 and 2) (Bleuler 
1911/1950; Kraepelin 1913; Schneider 1959).
The DSM and the extinction 
of the diagnosis of “neurosis”
The Diagnostic and Statistical Manual for Mental Disorders 
(DSM), the most widely accepted and authoritative publica-
tion of deﬁ  nitions and classiﬁ  cations of mental disorders, 
ﬁ  rst addressed the problems of deﬁ  nition and nomenclature 
for mental disorders. Reﬂ  ecting the multiple, idiosyncratic 
subtypes of the neuroses and the schizophrenias, the DSM, 
Second Edition (DSM-II) (APA 1968) listed 10 neurotic 
disorder subtypes and 12 schizophrenic subtypes (Tables 1a 
and 2). For some diagnoses but not others, beginning with 
the DSM-III (APA 1980) there was an attempt to replace 
subjective observations and opinions with available scientiﬁ  c 
data as the basis for subtypes and diagnostic criteria. This led 
to substantial changes in the DSM-III (APA 1980) regarding 
the neuroses but not the schizophrenias. Recognizing that 
the diagnosis of neurosis was confusing, misunderstood, 
socially stigmatizing and lacked a scientiﬁ  c basis, the DSM-
III (APA 1980) eliminated the term “neurosis” from the 
ofﬁ  cial nomenclature and either dropped or reorganized and 
renamed its subtypes. Some were renamed and integrated into 
other diagnostic categories such as the anxiety disorders. In 
contrast, there have been minimal changes in the diagnostic 
criteria for the schizophrenias and their subtypes since the 
1800’s. Of the nine core subtypes of schizophrenia for adults 
listed in the DSM-II (1968), six remain in the DSM-IV-TR 
(2000) (Tables 1 and 2). Only “simple” and “acute schizo-
phrenic episode” have been dropped. “Latent” has been 
compressed into “residual” and schizoaffective disorder is 
still given in the section on schizophrenia although it is no 
longer considered a speciﬁ  c subtype.
The history of the concept 
of the schizophrenias
Descriptions of aberrant, psychotic behaviors have been 
recorded for over 4000 years, with textbooks of Psychiatry 
attributing the ancient cases to schizophrenia. However, 
these ancient writings were certainly descriptive of psychotic 
behavior but not speciﬁ  c to any particular disease. The “mod-
ern” history of schizophrenia, ﬁ  rst called dementia praecox or 
dementia of the young, dates to the mid-1800s (Doran et al 
1986). Morel, in 1860, ﬁ  rst used this term to describe young 
patients who had suffered “developmental arrest and person-
ality disorganization” with dysfunction somewhat similar to 
old-age dementia. In the early 1870s Hecker added a subtype 
Table 1 From the Diagnostic and Statistical Manual of Mental 
Disorders, Second Edition (DSM-II; published in 1968)






.0  Schizophrenia, simple type
.1  Schizophrenia, hebephrenic type
.2  Schizophrenia, catatonic type
.23  Schizophrenia, catatonic type, excited
.24  Schizophrenia, catatonic type, withdrawn
.3  Schizophrenia, paranoid type
.4 Acute  schizophrenic  episode
.5  Schizophrenia, latent type
.6  Schizophrenia, residual type
.7  Schizophrenia, schizo-affective type
.73  Schizophrenia, schizo-affective type, excited
.74  Schizophrenia, schizo-affective type, depressed
.8  Schizophrenia, childhood type
.9  Schizophrenia, chronic undifferentiated type






.0 Anxiety  neurosis
.1 Hysterical  neurosis
.13  Hysterical neurosis, conversion type
.14  Hysterical neurosis, dissociative type
.2 Phobic  neurosis
.3  Obsessive compulsive neurosis
.4 Depressive  neurosis
.5  Neurasthenic neurosis (Neurasthenia)
.6 Depersonalization  neurosis 
.7 Hypochondriacal  neurosis
.8 Other  neurosis
.9 Unspeciﬁ  ed neurosisNeuropsychiatric Disease and Treatment 2007:3(1) 135
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of dementia praecox, hebephrenia (now called disorganized 
schizophrenia) and 3 years later Kahlbaum named catatonia as 
a second subtype (Bleuler 1911/1950). Kraepelin, in the 1880s, 
described the paranoid subtype and divided severe mental 
illness into dementia praecox and manic-depressive insanity 
(now called bipolar mood disorder) that, he wrote, had a mild, 
remitting course (Kraepelin 1913). E. Bleuler ﬁ  rst used “schizo-
phrenia” instead of dementia praecox in 1911 to describe an 
incapacitating and often unremitting disease of early-adulthood 
onset that he recognized as differing from dementia because 
memory and orientation remained intact (Bleuler 1911/1950). 
He incorporated the three subtypes noted above and established 
broad diagnostic criteria called “fundamental symptoms,” as 
well as the accessory symptoms of hallucinations and delusions 
(Tables 2, 3) (Bleuler 1911/1950; APA 2000). The fundamental 
symptoms, known as Bleuler’s “four As” were considered 
diagnostic well into the 1970s but only “ﬂ  at affect” remains in 
use today as one of the three “negative symptoms” of schizo-
phrenia (APA 2000). Bleuler taught that schizophrenia was 
the most common mental illness after mental retardation and 
alcoholism and emphasized that hallucinations and/or delusions 
without identiﬁ  able organic origin, although not mandatory 
for the diagnosis, were disease speciﬁ  c for schizophrenia. In 
1959, Schneider reinforced Bleuler’s broad perspective on 
schizophrenia and minimization of bipolar in concluding that 
any one of his own “ﬁ  rst-rank symptoms of schizophrenia” was 
pathognomonic of schizophrenia (Table 4) (Schneider 1959). 
Schneider agreed that the presence of hallucinations and/or 
delusions mandated a diagnosis of schizophrenia, regardless 
of even marked alterations in mood. According to Bleuler and 
Schneider there could be no psychotic mood disorder. Later 
editions of the DSM narrowed the deﬁ  nition of schizophrenia 
by requiring (and equating) the presence of psychotic symptoms 
such as hallucinations, delusions, disorganization and catatonia 
for a set period of time. Bleuler’s extremely general “funda-
mental symptoms” were mostly eliminated as diagnostic but 
Table 2 DSM-IV-TR section on schizophrenia (modiﬁ  ed for brevity)
a. Diagnostic criteria
A. Characteristic symptoms (Sx): patients must have 2 Sx during a 1 month (active) phase(1):
 (1)  delusions
 (2)  hallucinations
  (3) disorganized speech (frequent derailment, incoherence)
  (4) grossly disorganized or catatonic behavior
  (5) negative symptoms (affective ﬂ  attening, alogia, or avolition)
  [NOTE: Only 1 symptom is required if delusions are bizarre or hallucinations are a voice commenting on one’s behavior/thoughts; or 2 or    
  more voices are conversing with each other] (1, 2)
B. Social/occupational dysfunction: work, interpersonal relations or self-care have markedly deteriorated (1)
C. Duration: continuous signs for 6 months with a 1 month active phase (may include prodromal or residual symptoms) (1)
D. Exclude schizoaffective and mood disorder with psychotic features (3)
E.  Exclude substance and general medical condition (1)
F.  Exclude preexisting pervasive developmental disorder (1)
b. Subtypes of schizophrenia(1)
1) Paranoid type, (initiated by Kraepelin, 1880): Preoccupation with one or more delusions or frequent auditory hallucinations; no prominent disorga 
  nization of speech, no disorganized or catatonic behavior or ﬂ  at or inappropriate affect (1).
2) Disorganized type, (initiated by Hecker, 1871): All of the following are prominent: disorganized speech and behavior, ﬂ  at or inappropriate affect  
 without  catatonia.
3) Catatonic type, (initiated by Kahlbaum, 1874): (1) motoric immobility including waxy ﬂ  exibility or stupor; (2) excessive but purposeless motor  
  activity; (3) extreme negativism or mutism; (4) peculiarities of voluntary movement to include inappropriate or bizarre posturing, stereotyped 
  movements, prominent mannerisms or grimacing; (5) echolalia or echopraxia (1).
4) Undifferentiated type: Symptoms from criterion A for schizophrenia (characteristic symptoms) present but without the criteria given above for the  
  paranoid, disorganized or catatonic types (1).
5) Residual type, (similar to E. Bleuler’s latent subtype, 1911): absence of prominent delusions, hallucinations, disorganized speech or behavior or   
  catatonia; presence of continuing evidence of the disturbance, ie, negative symptoms or 2 or more symptoms from criterion A of schizophrenia in  
  an attenuated form, ie, odd beliefs or unusual perceptual experiences(1).
(1) the symptoms/criteria in each of these sections of the diagnostic criteria that “deﬁ  ne” schizophrenia, ie, A, B, C, E, and F and the symptoms of the subtypes are disease 
non-speciﬁ  c and occur frequently in mood disorders, severe with psychotic features
(2) these qualiﬁ  cations that allow a diagnosis of schizophrenia with only one of the characteristic symptoms in section A is from K. Schneider’s ﬁ  rst rank symptoms (see Table 4)
(3) criterion D is under emphasized and often overlooked when psychotic symptoms from criterion A are elicited, especially in the US (in contrast to UK)Neuropsychiatric Disease and Treatment 2007:3(1) 136
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Schneider’s “ﬁ  rst-rank symptoms” remain especially diagnostic 
(compare Tables 2, 3, and 4).
Doubt about the schizophrenias: 
the non-speciﬁ  city of the diagnostic 
criteria and chronicity of course
The ﬁ  rst departure from Kraepelin’s initial description of two 
separate diseases, dementia praecox and manic depressive 
insanity, came from Kraepelin himself in 1920 when he re-
canted somewhat, stating, “It is becoming increasingly clear 
that we cannot distinguish satisfactorily between these two 
illnesses and this brings home the suspicion that our formula-
tion of the problem may be incorrect” (Crow 1990; Taylor 
1993). Another movement away from Bleuler’s concept 
equating psychosis with schizophrenia and toward a single 
disease to explain psychoses came in 1933 with Kasanin’s 
new diagnosis, “schizoaffective psychosis”, describing psy-
chotic patients with symptoms of mania or depression and 
moving the diagnoses of some psychotic patients away from 
schizophrenia and toward mood disorders (Kasanin 1933). The 
wide acceptance of the predominance of schizophrenia over 
bipolar in psychotic patients may have discouraged Kasanin 
from diagnosing his patients “psychotic manic-depressives” 
and his schizoaffective concept was not widely embraced for 
several decades (Lake and Hurwitz 2006a).
Skepticism about the disease speciﬁ  city of psychotic 
symptoms and the prevalence of schizophrenia over psychotic 
mood disorders appeared in the psychiatric literature by the 
1970s. In 1978, Pope and Lipinski reviewed 166 papers dealing 
with the predictive value of “schizophrenic” symptoms and 
course, outcome, lithium response and family history in pa-
tients diagnosed with schizophrenia (Pope and Lipinski 1978). 
They and others concluded that there are no pathognomonic 
symptoms, courses, or outcomes that are speciﬁ  c to or valid in 
diagnosing schizophrenia (Kendell and Gourlay 1970; Fowler 
et al 1972; Ollerenshaw 1973; Abrams et al 1974; Pope and 
Lipinski 1978; Pope 1983; Dieperink and Sands 1996; Lake 
and Hurwitz 2006b). Conclusions by Pope and Lipinski, still 
relevant today, include: 1) “It seems likely that the ﬁ  ndings 
summarized in this review (that many schizophrenics are 
actually misdiagnosed, mood-disordered patients) have not 
been adequately acknowledged by many modern American 
diagnosticians.” 2) “The non-speciﬁ  city of ‘schizophrenic’ 
symptoms brings into question all research that uses them as 
the primary method of diagnosis” (Pope and Lipinski 1978). 
Further evidence for the subjectivity of the diagnostic criteria 
Table 3 E. Bleuler’s pathognomonic symptoms and other signs of schizophrenia
a. 4 As of schizophrenia/fundamental symptoms(1)
1) Ambivalence(2) (can be normal or due to distractibility)(3)
2) Affect, inappropriate(2) (usually due to anxiety and embarrassment)
3) Associations, loose(2) (likely represents distractibility, racing thoughts, and ﬂ  ight of ideas associated with mania)(4)




c. Other signs often thought indicative of schizophrenia(1,4)
1) Loner, poor premorbid personality (2)
2) Onset of psychotic illness in late adolescence or early adulthood(4)
3) A disorder of thought; formal thought disorder(4)
4) Derailment, tangentiality, loose associations, disorganization, blocking, incoherence, word salad, clanging, echolalia, echopraxia, speaking in tongues(4)
5) Catatonia(1,4)
6) Coprophagia, coprophilia(4)
7) Downward drift in society and employment (2,4)
8) Multiple, brief jobs (2,4)
9) Street person (2,4)
10) Ideas of control or reference, paranoia (2,4)
11) Mood incongruent hallucinations and/or delusions(4)
(1) none of these symptoms alone or in any combination, are disease speciﬁ  c; they occur frequently in severe mood disorders with psychotic features
(2) these signs and symptoms can overlap with normal behavior or be caused by multiple circumstances or causes other than a psychotic process
(3) statements in parentheses added by author
(4) common in severe mood disorders.Neuropsychiatric Disease and Treatment 2007:3(1) 137
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comes from the discrepancy in the prevalence of diagnoses 
used for psychotic patients between the UK and the US with 
the diagnosis of psychotic bipolar disorder rather than schizo-
phrenia more common in the UK than the US (Kendell and 
Gourlay 1970; Cooper et al 1972; Ollerenshaw 1973). 
The mood disorders section of the DSM-IV-TR (APA 
2000) recognizes that the psychotic features (hallucinations, 
delusions, disorganization and catatonia), and the chronic, 
persistent course, traditionally diagnostic for schizophrenia, 
occur in mood disorders that are severe with psychotic fea-
tures (Table 5). According to the clinical literature, mood-
congruent or mood-incongruent hallucinations and/or delu-
sions occur in 50%–80% of acutely manic patients (Carlson 
and Goodwin 1973; Guze et al 1975; Tohen et al 1992). 
Disorganization of speech, thought, and behavior —criteria 
supposedly speciﬁ  c for schizophrenia—occur in most, if 
not all, hospitalized manic or mixed bipolar patients and are 
indicative of mania. Catatonia is accounted for by severe 
bipolar over 71% of the time (Kruger and Braunig 2000). In 
the DSM-IV-TR (APA 2000) catatonia is a core diagnostic 
symptom and a major subtype of schizophrenia (Table 2) but 
in the DSM section on mood disorders, the wording for cata-
tonia as a “speciﬁ  er” is the same (compare Tables 2, b,3 and 
5,c). The “negative characteristic symptoms” from Criterion 
A for schizophrenia are most likely due to severe depression. 
Paranoia, another subtype and a diagnostic criterion of 
schizophrenia, typically “hides” the guilt or grandiosity of 
a psychotic mood disorder (Lake CR Unpublished 2007). 
According to the DSM-IV-TR (APA 2000) section on mood 
disorders, patients with psychotic mood disorders can evince 
all ﬁ  ve of the diagnostic symptoms for schizophrenia, sustain 
chronic, non-remitting courses, and yet not have schizophre-
nia. Criteria B, C, E, and F for schizophrenia are entirely com-
patible with mood disorders. Criterion D attempts to rule out 
psychotic mood disorders but can be overlooked or dismissed 
when psychotic features are focused upon in keeping with the 
traditional “hierarchical principle that schizophrenia takes pri-
ority” and that “even a trace of schizophrenia is schizophrenia” 
(Table 2) (Pope 1983; Maier et al 1992). 
More recent data reinforce the contention that hallucina-
tions and delusions are predominantly explained by psychotic 
mood disorders. Of 236 consecutive admissions with 
functional psychoses, 78% were diagnosed with psychotic 
mood disorders (Pini et al 2001). The percentage explained 
by psychotic mood increases to about 90% when the 12% 
diagnosed schizoaffective are moved to the psychotic mood 
category (Lake and Hurwitz 2006a). With such an overlap of 
diagnostic symptoms, the existence of two disorders rather 
than only one is questioned (Craddock and Owen 2005; Lake 
and Hurwitz 2006b). If only one disease, similarities and 
overlap in results from various basic science studies com-
paring patients diagnosed with schizophrenia and psychotic 
bipolar patients would be expected and would further indicate 
only one disorder to explain the psychoses.
Recent basic science data linking 
schizophrenia and psychotic bipolar 
disorder as one disease
Because schizophrenia was considered the most severe of 
psychiatric illnesses, research efforts to elucidate the cause 
of schizophrenia focused on comparisons of these patients 
with normal volunteers. Schizophrenia gained acceptance 
as hundreds, if not thousands, of studies found differences 
between schizophrenia and normals. However, in subsequent 
studies of psychotic bipolar or studies comparing schizo-
phrenia to psychotic bipolar, similarities and overlap have 
been reported. Speciﬁ  c examples of this phenomenon are 
the D-amino acid oxidase activator (DAOA/(G72)/G30) 
on chromosome 13q22-34 that was initially linked to 
Table 4 K. Schneider’s pathognomonic symptoms of 
schizophrenia
a. First rank symptoms(1)
1) Hearing one’s thoughts spoken aloud
2) Hearing voices arguing about oneself (2)
3) Hearing voices commenting on one’s actions (2)
4) Having bodily sensations imposed from outside
5) Having one’s thoughts/feelings inserted or withdrawn
by external sources
6) Having one’s thoughts broadcast
7) Having delusional perceptions
b. Second rank symptoms(1)
1) Other disorders of perception (3)
2) Sudden delusional ideas
3) Perplexity (3)
4) Depressive and euphoric mood changes (4)
5) Feelings of emotional impoverishment (3)
6) “... and several others as well” (3)
(1) none of these symptoms alone or any combination, are disease speciﬁ  c and they 
occur frequently in severe mood disorders with psychotic features
(2) either of these two symptoms are recognized as pathognomonic alone in the 
DSM-IV-TR since the presence of either by itself satisﬁ  es criteria under “NOTE” in 
section A, characteristic symptoms of schizophrenia (see Table 2)
(3) probably not indicative of any mental illness
(4) diagnostic of a mood disorder.Neuropsychiatric Disease and Treatment 2007:3(1) 138
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schizophrenia (Chumakov et al 2002) but subsequently 
found by at least 5 independent studies to be linked to bipolar 
(Badner and Gershon 2002; Hattori et al 2003; Schumacher 
et al 2004; Craddock et al 2005; Green et al 2005a,b) and the 
DISC-1 locus at 1q42 that was perhaps prematurely named 
“disrupted in schizophrenia” since it was ﬁ  rst associated 
with patients diagnosed schizophrenic (Millar et al 2000; 
Devon et al 2002). Similarly to the DAOA/G30 site, more 
recent data from several labs suggest linkage of DISC-1 to 
bipolar and “schizoaffective” pedigrees (Millar et al 2000; 
Blackwood et al 2001; Hodgkinson et al 2004; Macgregor 
et al 2004; Hamshere et al 2005). 
A recent, selected, rapidly expanding and provocative 
literature from diverse basic science laboratories in the 
US and UK demonstrates surprising similarities between 
schizophrenia and psychotic mood disorders, similarities 
that should not occur if these are two distinct disorders. A 
2005 editorial noted that “. . . of the (eleven) chromosome 
loci found for the transmission of schizophrenia and bipolar 
disorder, eight have been found to overlap . . ” (Fawcett 
2005). Selected results also showing similarities derive from 
genetic (Berrettini 2000, 2001, 2003; Cardno et al 2002; 
Schurhoff et al 2003; Korn 2004; Schumacher et al 2004; 
Craddock and Owen 2005; Craddock et al 2005; Fawcett 
2005; Green et al 2005a; Hamshere et al 2005; Schulze et al 
2005), imaging (Roy et al 1998; Bilder et al 1999; Dasari et al 
1999), auditory evoked potential (Olincy and Martin 2005), 
brain metabolic (al-Mousawi et al 1996; Cohen et al 1998), 
neurochemical (Knable et al 2001; Koh et al 2003; Tkachev 
et al 2003; Rosack 2003), and epidemiological (Berrettini 
2000; Korn 2004) studies. 
More details from the literature noted above are enlight-
ening. The two disorders overlap extensively in epidemio-
logical aspects including age of onset, lifetime risk, course 
of illness, worldwide distribution, risk for suicide, gender 
inﬂ  uence, and genetic susceptibility (Berrettini 2000). Korn 
Table 5 DSM-IV-TR diagnostic criteria and speciﬁ  ers for mood disorders (d/o) and mania (modiﬁ  ed for brevity)
a. Diagnostic criteria for a manic episode (deﬁ  nes bipolar mood D/O)
A. Distinct period ≥ 1 week (or inpatient hospitalization necessary) of abnormal and
persistently elevated, expansive or irritable mood
B. In the period, 3 symptoms (4 if mood is only irritable) persist to a signiﬁ  cant degree:
 1)  distractibility
  2) insomnia with increased energy
  3) grandiosity/increased self-esteem
 4)  ﬂ  ight of ideas
  5) increased activities: including phoning, spending, travel, investing, gambling, sex; excessive involvement in pleasurable activities with high 
    potential for negative outcome
  6) speech: pressed to incoherent (1)
  7) thoughts: racing, loose, tangential(1)
C. Symptoms cause marked impairment in functioning(1) (job, social, family) or hospitalization(1) warranted because of severity of symptoms
D. Symptoms not due to substance or general medical condition
b. Speciﬁ  ers for mood D/O diagnoses
A. Presenting state:
  - for BP: manic, depressed, mixed 
  - for UP: single episode or recurrent
B. Severity: mild, moderate, severe without, severe with psychotic features (1), partial, full remission
C. Course/Onset: chronic (symptoms > 2 years) (1), seasonal affective D/O, rapid cycling (1) (≥ 4 episodes/year), postpartum onset (within 4 weeks),  
  with or without full interepisode recovery (1)
D. Features: catatonic (1), melancholic, atypical(1)
c. Catatonic features speciﬁ  er
(1) motoric immobility including waxy ﬂ  exibility or stupor; (2) excessive but purposeless motor activity; (3) extreme negativism or mutism; (4) 
peculiarities of voluntary movement to include inappropriate or bizarre posturing, stereotyped movements, prominent mannerisms or grimacing; (5) 
echolalia or echopraxia (1).
(1)underlines added to denote symptoms that can cause the misdiagnosis of schizophrenia or are listed in the DSM-IV-TR section on schizophrenia as diagnostically speciﬁ  c 
for and/or as a subtype of schizophrenia.Neuropsychiatric Disease and Treatment 2007:3(1) 139
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(2004) ﬁ  nds similarities in “family studies, genetic analyses, 
common symptom complexes and psychopharmacological 
responses” and implies that the “evolving interface be-
tween the two disorders is closing”. One author suggests 
that schizophrenia and bipolar disorders are “chemical 
cousins” (Rosack 2003). Cardno et al (2002) applied a 
“biometrical model ﬁ  tting” to clinical data from twins to 
investigate whether schizophrenia and manic-depressive 
disorder share genetic risk factors. Results of their studies 
of 77 monozygotic and 89 same-sex dizygotic twin pairs 
indicate “signiﬁ  cant genetic correlations” between these 
two disorders. The authors conclude that “there is a degree 
of overlap in the genes contributing” to schizophrenia and 
bipolar disorder. At least two groups, Schulze et al (2005) 
and Schurhoff et al (2003) ﬁ  nd that delusional proneness is 
an inherited predisposition common to schizophrenia and 
bipolar. The DAOA/GT30 locus on 13q34 appears to confer 
persecutory delusions similarly in schizophrenia and bipolar 
implying genotypic overlap (Schultz et al 2005). Based on 
their molecular genetic research, Craddock and Owen (2005) 
published an editorial titled “The beginning of the end for the 
Kraepelinian dichotomy” and conclude that, “Now molecular 
genetic studies are beginning to challenge and will soon, we 
predict, overturn the traditional dichotomous view” (that 
schizophrenia and bipolar are separate).
Tkachev et al (2003) studied the oligodendrocyte-speciﬁ  c 
and myelination-associated gene expression in schizophrenia 
and bipolar disorder ﬁ  nding similar downregulation of key 
genes, including transcription factors that regulate these 
genes, in schizophrenic and bipolar brains, as compared to 
controls. They conclude that there are “similar expression 
changes” in schizophrenic and bipolar brains which, they 
state, “lends support to the notion that these disorders share 
common causative and pathophysiological pathways”. Koh 
et al (2003) identiﬁ  ed a recently recognized group of dopa-
mine receptor-interacting proteins as possible novel sites of 
dysfunction in schizophrenic and bipolar patients. This group, 
studying tissue from the Stanley Foundation Neuropathol-
ogy Consortium, ﬁ  nd that the dorsolateral prefrontal cortex 
in both schizophrenic and bipolar brains has signiﬁ  cantly 
elevated levels of the D2 dopamine receptor-desensitization 
regulatory protein, neuronal calcium sensor-1. Their study 
“supports the hypothesis that schizophrenia and bipolar 
disorder may be associated with abnormalities in dopamine 
receptor-interacting proteins”.
We acknowledge that there are ample data indicating that 
the two diseases are separate (Alsthuler et al 2000; Lapierre 
1994) but question whether the diagnostic confounders re-
lated to non-speciﬁ  city of diagnostic symptoms invalidate 
some of these conclusions. The patients in the “schizophre-
nia” study groups might really suffer from severe psychotic 
bipolar (Pope and Lipinski 1978). Differences in comparative 
studies might be explained by inherent variabilities across 
the spectrum of severity between “ordinary” and severely 
psychotic bipolar patients. The conclusions of some reviews 
are ambivalent regarding similarities and differences between 
the two (Ketter et al 2004).
Several authors including Taylor (1993) and Crow (1990) 
imply that the three psychotic diseases, schizophrenia, 
schizoaffective and bipolar disorders, form a spectrum of se-
verity (Dieperink and Sands 1996; Kendell and Gourlay 1970; 
Moller 2003; Ollerenshaw 1973). We extend this hypothesis to 
propose that only one disease, psychotic bipolar disorder, has 
such a wide spectrum of severity of symptoms and chronicity 
of course without remission, that it alone can explain all three 
of the current psychotic diagnoses. A basic tenet of medicine 
states that if one disease can explain a spectrum of symptoms 
that generate two or more diagnoses, there is likely only one 
disease, in this case, a mood disorder.
If psychotic patients do not have 
schizophrenia or symptoms of a 
mood disturbance, what do they 
have?
Severely psychotic mood patients can suffer psychotic 
symptoms that obscure mood symptoms for months (Post 
1992; Korn 2004). Such patients typically do not complain 
of their mood symptoms in their initial diagnostic interviews 
but often focus instead on paranoid symptoms if they are 
able to communicate at all (Lake 2006). The absence of 
obvious mood symptoms in patients presenting in psychotic 
states warrants aggressive pursuit of symptoms of a mood 
disturbance from such patients and any signiﬁ  cant others 
available. In those psychotic patients still without obvious 
current or past mood symptoms, we suggest a temporary 
diagnosis of “psychotic disorder not otherwise speciﬁ  ed” 
while mood symptoms or subtle organic causes are pursued. 
This diagnosis is already in place in the DSM-IV-TR, code 
number 298.9 (APA 2000). A less stigmatizing diagnosis 
than schizophrenia, it more accurately reﬂ  ects our knowledge 
or lack thereof. As noted by Swartz and reviewed by Martin, 
there are multiple subtle organic causes of psychosis such 
as epilepsy, tardive psychosis, congenital abnormalities, Neuropsychiatric Disease and Treatment 2007:3(1) 140
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obstetric brain trauma, stroke and narcolepsy (Martin 1983; 
Doran et al 1986; Swartz 1995, 2002, 2004; Douglass 2003). 
Further, past use of phencyclidine or other neurotoxic, “de-
signer”, or illegal drugs can cause a chronic psychosis and 
may not be identiﬁ  ed in drug screens.
The scientiﬁ  c data supporting 
schizophrenia and bipolar disorder 
as “bona-ﬁ  de” diseases
A sound scientiﬁ  c basis for establishing a disease demands 
diagnostic criteria or pathophysiology that are unique and 
speciﬁ  c for that disease. The belief that hallucinations, 
delusions, and a chronic course are disease speciﬁ  c for 
schizophrenia has been widely held and all research data 
are based on this presumption, leading to the accumulation 
of “a massive body of clinical and biological evidence” and 
lending conﬁ  dence as to the validity of schizophrenia as 
a “bona-ﬁ  de” disease (Pope and Lipinski 1978; Nasrallah 
2006). Despite recognition that these “diagnostic” symptoms 
for schizophrenia are disease non-speciﬁ  c, its acceptance as 
a disease is so ﬁ  rmly entrenched that it persists. In contrast 
to schizophrenia, for classic bipolar disorder, the changes 
in behavior and cognition are so extreme between mania 
and depression in the same patients that the diagnostic 
symptoms are strikingly unique and widely different from 
euthymia or any other medical condition. No other disease 
causes such a pattern of symptom occurrence. Descriptions 
of such cycling have been numerous and consistent for over 
2000 years (Goodwin and Jamison 1990). Such “classic” 
patients are identiﬁ  able with a high degree of conﬁ  dence. 
These characteristic symptoms and cycling courses have 
been identiﬁ  ed and constitute disease-speciﬁ  c diagnostic 
criteria that are given in the DMS-IV-TR (Table 5) (APA 
2000). Patients with cycles of the characteristic symptoms 
have been rigorously diagnosed and sequestered on research 
units and have demonstrated consistent genetic (Barrett et al 
2003; Green et al 2005a, b), epidemiologic (Berrettini 2000, 
2001, 2003) and pharmacologic (Carlson and Goodwin 1973; 
Korn 2004) results, validating bipolar mood disorder as a 
speciﬁ  c disease (Table 6) (Goodwin and Jamison 1990). 
For the mood disorders, hallucinations and delusions only 
indicate the level of severity and are not utilized as diagnostic 
criteria, as they are for schizophrenia. Further documentation 
of the veracity of bipolar stems from several candidate bipolar 
susceptibility loci that have been recently isolated (Barrett 
et al 2003; Green et al 2005a, b). Patients studied on research 
units for schizophrenia were selected primarily because they 
evidenced hallucinations and/or delusions (Table 6). As 
implied by Pope and Lipinski, many, if not most, of these 
patients suffered from psychotic bipolar disorder and putting 
research conclusions about schizophrenia in doubt (Pope and 
Lipinski 1978; Lake and Hurwitz 2006a,b).
Why the schizophrenias have not 
followed the neuroses
The concept of schizophrenia as “insanity” was narrowly 
focused, with high morbidity and chronicity usually re-
quiring hospitalization. The costs for patients diagnosed 
with schizophrenia on government disability status have 
garnered considerable attention from government, taxpay-
ers, and society in general. The neuroses, which may have 
been more common but were usually managed in outpatient 
clinics at lower costs received less attention and rarely 
had disability status. As a result, hundreds of millions of 
federal dollars have funded research on the schizophre-
nias while relatively few dollars have supported research 
into the neuroses. Like numbers of pharmaceutical dollars 
have supported the development and clinical trials of new 
antipsychotic or “anti-schizophrenic” drugs, encouraging 
the diagnosis of schizophrenia and solidifying it as a dis-
ease. These factors have stimulated research that generated 
lectures, seminars and publications about schizophrenia, 
including at least 3 journals dedicated to schizophrenia 
alone. Such a large database magniﬁ  ed the importance of 
schizophrenia as a “bona-ﬁ  de” disease. The power base of 
researchers, academics, editors and administrators invested 
in the schizophrenias has been greater and more inﬂ  uential 
than that of those studying the neuroses. Schizophrenia has 
received media attention both in the news and in ﬁ  lm and has 
been evoked as the explanation for numerous high-proﬁ  le 
murders. The term “schizophrenic” is misused as an adjec-
tive in the media and by the public to signify “ﬂ  ip-ﬂ  ops” in 
behaviors, statements or policies. For reasons such as these, 
schizophrenia has maintained its place as the most widely-
known mental disorder in the world.
Summary
The schizophrenias, like the neuroses, 1) were described 
in the 19th century, 2) have diagnostic symptoms based on 
observation and opinion, 3) have no disease-speciﬁ  c signs or 
symptoms, 4) convey considerable social stigma, and 5) are 
confusing and misunderstood by many including the public 
and the media. A distinctive pathophysiology for schizo-
phrenia remains elusive despite enormous, costly research Neuropsychiatric Disease and Treatment 2007:3(1) 141
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efforts. While bipolar disorder is scientiﬁ  cally grounded 
as a “bona-ﬁ  de” disease, schizophrenia is not. So what is 
schizophrenia?
The select clinical and recent, diverse basic science litera-
ture summarized above is striking in its consistency of results 
which indicate that schizophrenia and psychotic bipolar 
disorder are more alike than different over a wide array of 
variables. Many, if not most, of the patients diagnosed with 
schizophrenia in research studies may have suffered from 
psychotic mood disorders (Pope and Lipinski 1978). Taken 
together, these data invite speculation that schizophrenia 
and bipolar disorder are in fact one, and that schizophrenia, 
previously identiﬁ  ed by psychotic symptoms, is really the 
extreme end of the severity continuum of bipolar mood dis-
order and not a different disease. Three psychotic disorders 
would have traditionally been invoked to account for the 
severity continuum of only one disease—a mood disorder 
that is now recognized to evince the furthest extremes of 
insanity. Such a mood disorder can be sufﬁ  ciently severe, 
with an overwhelming predominance of psychotic features, 
to obscure obvious mood symptoms. 
The potential for negative outcomes is substantial for mood-
disordered patients who are misdiagnosed with schizophrenia, 
in that instead of ﬁ  rst-line mood stabilizing drugs they are given 
antipsychotic drugs in greater doses and for longer periods of 
time. Bipolar patients cycle faster and get worse without ﬁ  rst-
line mood-stabilizing drugs and they get antipsychotic drugs 
with more malignant side-effect proﬁ  les (Dieperink and Sands 
1996; Carlson and Goodwin 1973). Social stigma associated 
with schizophrenia is considerably more detrimental than that 
of most other mental health disorders. 
Among psychotic patients, adoption of the assumption 
that “even a trace of mood disturbance is a mood disorder” 
seems appropriate. In the small percentage of psychotic pa-
tients who have no current or historic mood disturbances, a 
diagnosis of “psychotic disorder not otherwise speciﬁ  ed” is 
more useful and safer than schizophrenia. The literature of 
this review, though selected, is substantial and persuasive. 
The authors recognize that its thesis is controversial and 
may be received with skepticism or dismissed; nevertheless, 
it may be time to consider retiring the historic diagnosis of 
schizophrenia as were the neuroses and covered wagons.
Table 6 Scientiﬁ  c bases for bipolar (BP) disorder (D/O) and for schizophrenia
a. Bipolar mood D/O
1) The striking extremes in mood and behavior from mania to depression that occur in cycles in  the same individuals make such patients easy to 
identify with conﬁ  dence. These symptoms of BP mood D/O have been described in patients for over 2000 years, date from 100 BC and have been 
numerous and consistent. These symptoms form the diagnostic criteria in the DSM-IV-TR and do not include hallucinations and delusions that only 
indicate level of severity for the BP D/O.
2) That these diagnostic criteria deﬁ  ne a speciﬁ  c disease, ie, BP mood D/O, has been veriﬁ  ed over the past 30 years by several lines of data; patients 
with the diagnostic criteria of BP mood D/O from the DSM have been gathered on research units, studied, and have yielded consistent data; they: 
  - Respond to Lithium (large, double blind, placebo controlled, crossover studies)
  - Have a 10% concordance in primary family members including dizygotic twins
  - Have about a 70% concordance in monozygotic twins
  - When 1 parent has a BP-I D/O, any child has a 25% chance of developing a mood D/O; when both parents have BP-I, any child has a 50%–70%  
   chance
 -    Adoption studies show that biological children of affected parents remain at the same risk even if adopted in infancy by non-affected families
  - Gene studies of several large families with a high prevalence of BP D/O have identiﬁ  ed speciﬁ  c loci in affected individuals (loci different across  
    the different families) 
  - When treated with MAO-Is, TCAs, or SSRIs, 10%–15% of BP depressed patients can “switch” into mania (these antidepressants effect 
     neurotransmitters involved in modulation of mood)
  - BP D/Os have a tight age of onset distribution (mean, about 20 years)
  - Have a generally predictable and common course (pattern of cycles that shorten with relapses and occur more frequently)
b. Schizophrenia:
Our current concept of Schizophrenia is based on the 19th and early 20th century observations, descriptions and beliefs of E. Bleuler and later K.  
Schneider, who stated that hallucinations and delusions were unique to Schizophrenia after organicity is ruled out. By their criteria a patient cannot  
have a primary diagnosis of mood D/O and have hallucinations or delusions. The DSM-IV-TR (2000) essentially endorses their descriptive, non-
disease speciﬁ  c diagnostic criteria in the section on Schizophrenia while under the mood D/O section, the DSM acknowledges the potential for 
hallucinations, delusions, disorganization, catatonia, chronic presence of symptoms and the absence of a full interepisode recovery in a mood D/O 
patient.
Abbreviations: BP, bipolar; D/O, disorder; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision; MAO-I, monoamine oxidase inhibitor; 
TCA, tricyclic antidepressant; SSRI, serotonin speciﬁ  c reuptake inhibitor.Neuropsychiatric Disease and Treatment 2007:3(1) 142
Lake and Hurwitz
This review has shortcomings. We may have inadver-
tently missed some comparative studies that documented 
differences. There is as yet no deﬁ  nitive pathophysiology to 
conclude that these are one or two diseases. The overlap in 
susceptibility loci provides for the most compelling argument 
for a single disease but a positive conclusion awaits further 
molecular genetic studies.
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